Carboplatin and Rhabdomyolysis - a phase IV clinical study of FDA data

Summary:

Rhabdomyolysis is reported as a side effect among people who take Carboplatin (carboplatin), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Paclitaxel, and have High blood pressure.

The phase IV clinical study analyzes which people have Rhabdomyolysis when taking Carboplatin. It is created by eHealthMe based on reports of 127,949 people who have side effects when taking Carboplatin from the FDA, and is updated regularly.

What is Carboplatin?

Carboplatin has active ingredients of carboplatin. It is often used in cancer. eHealthMe is studying from 128,210 Carboplatin users. Check the latest studies of Carboplatin.

What is Rhabdomyolysis?

Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down) is found to be associated with 1,559 drugs and 1,920 conditions by eHealthMe. Check the latest studies of Rhabdomyolysis.

On Jul, 07, 2026

127,949 people reported to have side effects when taking Carboplatin.
Among them, 193 people (0.15%) have Rhabdomyolysis.

Among these 193 people:

* Approximation only. Some reports may have incomplete information.

Do you take Carboplatin and have Rhabdomyolysis?

- Check whether Rhabdomyolysis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Carboplatin:

Carboplatin (128,210 reports)

Rhabdomyolysis treatments and more:

Rhabdomyolysis (60,893 reports)

How severe was Rhabdomyolysis and when was it recovered:

Rhabdomyolysis in Carboplatin

Expand to all the drugs that have ingredients of carboplatin:

Rhabdomyolysis and drugs with ingredients of carboplatin (193 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Carboplatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rhabdomyolysis:

Rhabdomyolysis (1,559 drugs)

Browse all the conditions that are associated with Rhabdomyolysis:

Rhabdomyolysis (1,920 conditions)

Related publications that referenced our studies

Rezigh, A. B., Armenia, E., Li, T., & Soesilo, I. , "Rifaximin as a rare cause of rhabdomyolysis in cirrhosis", Clinical case reports, 2018 Jan .
Moye, P. M., Manasen, S., & O’Brien, K., "Sulfamethoxazole-Trimethoprim-Induced Rhabdomyolysis in an Immunocompetent Patient: A Case Report", Medicine, 2014 Jan .
Zakaria S, Lu KY, Nussenblatt V, Browner I, "Atrial flutter associated with carboplatin administration", Annals of Pharmacotherapy, 2011 Nov .
Rezigh, A. B., Armenia, E., Li, T., & Soesilo, I. , "Rifaximin as a rare cause of rhabdomyolysis in cirrhosis", Clinical case reports, 2018 Jan .
Moye, P. M., Manasen, S., & O’Brien, K., "Sulfamethoxazole-Trimethoprim-Induced Rhabdomyolysis in an Immunocompetent Patient: A Case Report", Medicine, 2014 Jan .
Zakaria S, Lu KY, Nussenblatt V, Browner I, "Atrial flutter associated with carboplatin administration", Annals of Pharmacotherapy, 2011 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on carboplatin (the active ingredients of Carboplatin) and Carboplatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.